114 related items for PubMed ID: 17228174
1. Involvement of transglutaminase-2 in pathological changes in renal disease.
Ikee R, Kobayashi S, Hemmi N, Saigusa T, Namikoshi T, Yamada M, Imakiire T, Kikuchi Y, Suzuki S, Miura S.
Nephron Clin Pract; 2007; 105(3):c139-46. PubMed ID: 17228174
[Abstract] [Full Text] [Related]
2. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
Arakawa T, Masaki T, Hirai T, Doi S, Kuratsune M, Arihiro K, Kohno N, Yorioka N.
Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750
[Abstract] [Full Text] [Related]
3. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
Rong ZH, Wang C, Hao J, Duan HJ.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):275-8. PubMed ID: 18471357
[Abstract] [Full Text] [Related]
4. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
Myllymäki J, Honkanen T, Syrjänen J, Helin H, Rantala I, Pasternack A, Mustonen J.
Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
[Abstract] [Full Text] [Related]
5. Proteinuria and renal function in relation to renal morphology. A clinicopathological study of IgA nephropathy at the time of kidney biopsy.
Widstam-Attorps U, Berg U, Bohman SO, Lefvert AK.
Clin Nephrol; 1992 Nov; 38(5):245-53. PubMed ID: 1451337
[Abstract] [Full Text] [Related]
6. The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy.
Ranieri E, Gesualdo L, Grandaliano G, Maiorano E, Schena FP.
J Nephrol; 2001 Nov; 14(4):253-62. PubMed ID: 11506247
[Abstract] [Full Text] [Related]
7. Pattern of renal beta 1(alpha 1-alpha 6) integrins distribution in IgA nephropathy and Henoch-Schoenlein nephritis.
Wagrowska-Danilewicz M, Danilewicz M.
Pol J Pathol; 2002 Nov; 53(2):51-7. PubMed ID: 12140867
[Abstract] [Full Text] [Related]
8. Nestin is a novel marker for renal tubulointerstitial injury in immunoglobulin A nephropathy.
Tomioka M, Hiromura K, Sakairi T, Takeuchi S, Maeshima A, Kaneko Y, Kuroiwa T, Takeuchi T, Nojima Y.
Nephrology (Carlton); 2010 Aug; 15(5):568-74. PubMed ID: 20649878
[Abstract] [Full Text] [Related]
9. A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis.
Wagrowska-Danilewicz M, Danilewicz M.
Pol J Pathol; 2002 Aug; 53(3):155-62. PubMed ID: 12476618
[Abstract] [Full Text] [Related]
10. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
Espinosa M, Ortega R, Gómez-Carrasco JM, López-Rubio F, López-Andreu M, López-Oliva MO, Aljama P.
Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
[Abstract] [Full Text] [Related]
11. The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis.
Paydas S, Balal M, Tanriverdi K, Sertdemir Y, Baslamisli F.
Ren Fail; 2007 Mar; 29(7):779-84. PubMed ID: 17994443
[Abstract] [Full Text] [Related]
12. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
Ikee R, Kobayashi S, Saigusa T, Namikoshi T, Yamada M, Hemmi N, Imakiire T, Kikuchi Y, Suzuki S, Miura S.
Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
[Abstract] [Full Text] [Related]
13. Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission.
Arikan H, Koc M, Cakalagaoglu F, Tuglular S, Ozener C, Akoglu E.
Nephrology (Carlton); 2009 Apr; 14(2):219-26. PubMed ID: 19298642
[Abstract] [Full Text] [Related]
14. Glomerulo-tubular junction stenosis as a factor contributing to glomerular obsolescence in IgA nephropathy.
Sato M, Hotta O, Taguma Y.
J Pathol; 2002 May; 197(1):14-9. PubMed ID: 12081198
[Abstract] [Full Text] [Related]
15. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy.
Sakamoto-Ihara T, Suzuki Y, Kurusu A, Yamashita M, Horikoshi S, Tomino Y.
Inflamm Res; 2007 Oct; 56(10):421-7. PubMed ID: 18026699
[Abstract] [Full Text] [Related]
16. Histological differences in new-onset IgA nephropathy between children and adults.
Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, Shimizu F, Nikolic-Paterson DJ, Uchiyama M.
Nephrol Dial Transplant; 2006 Dec; 21(12):3466-74. PubMed ID: 16935895
[Abstract] [Full Text] [Related]
17. Tenascin expression may reflect the activity and chronicity of human IgA nephropathy.
Masaki T, Yorioka N, Taniguchi Y, Oda H, Yamakido M.
Clin Nephrol; 1998 Oct; 50(4):205-13. PubMed ID: 9799064
[Abstract] [Full Text] [Related]
18. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
Guo W, Xu H, Huang WY, Chen J, Yang Y, Fu R, Liu HM, Zha XL, Zhang ZG.
Zhonghua Yi Xue Za Zhi; 2007 Jun 26; 87(24):1660-5. PubMed ID: 17825142
[Abstract] [Full Text] [Related]
19. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L, Zhang JJ, Lv JC, Liu G, Zou WZ, Zhao MH, Zhang H.
Nephrol Dial Transplant; 2008 Dec 26; 23(12):3921-7. PubMed ID: 18603547
[Abstract] [Full Text] [Related]
20. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
Jeong HJ, Park SK, Cho YM, Kim MS, Kim YS, Choi J, Kim SI, Lim BJ.
Hum Pathol; 2008 Oct 26; 39(10):1511-8. PubMed ID: 18620732
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
